by American Chemical Society This X-ray structure shows FTX-6058 bound to its protein target. Credit: Fulcrum Therapeutics For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms. Today, researchers will describe the discovery...
